Histopathologic characteristics of the primary tumor in breast cancer patients with isolated tumor cells of the sentinel node

Melissa Hulvat, Prabha Rajan, Elizabeth Rajan, Sharfi Sarker, Carol Schermer, Gerard Aranha, Katharine Yao

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Clinicians often rely on primary tumor characteristics to decide on adjuvant treatment for patients with breast cancer with isolated tumor cells (ITC) in the sentinel lymph node. The purpose of this study was to determine if there is a significant difference in primary tumor characteristics between ITC and other nodal groups. Methods: Patients undergoing sentinel lymphadenectomy were divided into 3 groups: N0, no metastases; ITC, metastasis less than 0.2 mm; and micro- or macrometastases (MM), metastasis greater than 0.2 mm. The chi-square test and analysis of variance were used. Results: A total of 552 patients underwent sentinel lymphadenectomy; 197 (36%) had tumor-positive sentinel lymph nodes. Of these, 35 (18%) were classified as ITC and 162 (82%) as MM. When primary tumor characteristics were compared, the ITC group had significantly more lymphovascular invasion and higher proliferative rate than the N0 group (P < .05) and significantly less lymphovascular invasion, lower proliferative rate, and smaller tumor size (P < .05) than the MM group. There were no significant differences in the age, hormone receptor status, histologic type, or tumor grade among the patient groups. Conclusions: Proliferation and lymphovascular invasion of the primary tumor are significantly different between the ITC, N0, and MM groups suggesting that ITC tumors may have different biology than the N0 or MM tumors.

Original languageEnglish (US)
Pages (from-to)518-524
Number of pages7
JournalSurgery
Volume144
Issue number4
DOIs
StatePublished - Oct 2008
Externally publishedYes

Fingerprint

Breast Neoplasms
Neoplasms
cyhalothrin
Neoplasm Metastasis
Lymph Node Excision
Neoplasm Micrometastasis
Chi-Square Distribution
Analysis of Variance
Hormones

ASJC Scopus subject areas

  • Surgery

Cite this

Histopathologic characteristics of the primary tumor in breast cancer patients with isolated tumor cells of the sentinel node. / Hulvat, Melissa; Rajan, Prabha; Rajan, Elizabeth; Sarker, Sharfi; Schermer, Carol; Aranha, Gerard; Yao, Katharine.

In: Surgery, Vol. 144, No. 4, 10.2008, p. 518-524.

Research output: Contribution to journalArticle

Hulvat, M, Rajan, P, Rajan, E, Sarker, S, Schermer, C, Aranha, G & Yao, K 2008, 'Histopathologic characteristics of the primary tumor in breast cancer patients with isolated tumor cells of the sentinel node', Surgery, vol. 144, no. 4, pp. 518-524. https://doi.org/10.1016/j.surg.2008.06.006
Hulvat, Melissa ; Rajan, Prabha ; Rajan, Elizabeth ; Sarker, Sharfi ; Schermer, Carol ; Aranha, Gerard ; Yao, Katharine. / Histopathologic characteristics of the primary tumor in breast cancer patients with isolated tumor cells of the sentinel node. In: Surgery. 2008 ; Vol. 144, No. 4. pp. 518-524.
@article{eab621dcdcfb4b71ab58bdb5eef8cca6,
title = "Histopathologic characteristics of the primary tumor in breast cancer patients with isolated tumor cells of the sentinel node",
abstract = "Background: Clinicians often rely on primary tumor characteristics to decide on adjuvant treatment for patients with breast cancer with isolated tumor cells (ITC) in the sentinel lymph node. The purpose of this study was to determine if there is a significant difference in primary tumor characteristics between ITC and other nodal groups. Methods: Patients undergoing sentinel lymphadenectomy were divided into 3 groups: N0, no metastases; ITC, metastasis less than 0.2 mm; and micro- or macrometastases (MM), metastasis greater than 0.2 mm. The chi-square test and analysis of variance were used. Results: A total of 552 patients underwent sentinel lymphadenectomy; 197 (36{\%}) had tumor-positive sentinel lymph nodes. Of these, 35 (18{\%}) were classified as ITC and 162 (82{\%}) as MM. When primary tumor characteristics were compared, the ITC group had significantly more lymphovascular invasion and higher proliferative rate than the N0 group (P < .05) and significantly less lymphovascular invasion, lower proliferative rate, and smaller tumor size (P < .05) than the MM group. There were no significant differences in the age, hormone receptor status, histologic type, or tumor grade among the patient groups. Conclusions: Proliferation and lymphovascular invasion of the primary tumor are significantly different between the ITC, N0, and MM groups suggesting that ITC tumors may have different biology than the N0 or MM tumors.",
author = "Melissa Hulvat and Prabha Rajan and Elizabeth Rajan and Sharfi Sarker and Carol Schermer and Gerard Aranha and Katharine Yao",
year = "2008",
month = "10",
doi = "10.1016/j.surg.2008.06.006",
language = "English (US)",
volume = "144",
pages = "518--524",
journal = "Surgery (United States)",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Histopathologic characteristics of the primary tumor in breast cancer patients with isolated tumor cells of the sentinel node

AU - Hulvat, Melissa

AU - Rajan, Prabha

AU - Rajan, Elizabeth

AU - Sarker, Sharfi

AU - Schermer, Carol

AU - Aranha, Gerard

AU - Yao, Katharine

PY - 2008/10

Y1 - 2008/10

N2 - Background: Clinicians often rely on primary tumor characteristics to decide on adjuvant treatment for patients with breast cancer with isolated tumor cells (ITC) in the sentinel lymph node. The purpose of this study was to determine if there is a significant difference in primary tumor characteristics between ITC and other nodal groups. Methods: Patients undergoing sentinel lymphadenectomy were divided into 3 groups: N0, no metastases; ITC, metastasis less than 0.2 mm; and micro- or macrometastases (MM), metastasis greater than 0.2 mm. The chi-square test and analysis of variance were used. Results: A total of 552 patients underwent sentinel lymphadenectomy; 197 (36%) had tumor-positive sentinel lymph nodes. Of these, 35 (18%) were classified as ITC and 162 (82%) as MM. When primary tumor characteristics were compared, the ITC group had significantly more lymphovascular invasion and higher proliferative rate than the N0 group (P < .05) and significantly less lymphovascular invasion, lower proliferative rate, and smaller tumor size (P < .05) than the MM group. There were no significant differences in the age, hormone receptor status, histologic type, or tumor grade among the patient groups. Conclusions: Proliferation and lymphovascular invasion of the primary tumor are significantly different between the ITC, N0, and MM groups suggesting that ITC tumors may have different biology than the N0 or MM tumors.

AB - Background: Clinicians often rely on primary tumor characteristics to decide on adjuvant treatment for patients with breast cancer with isolated tumor cells (ITC) in the sentinel lymph node. The purpose of this study was to determine if there is a significant difference in primary tumor characteristics between ITC and other nodal groups. Methods: Patients undergoing sentinel lymphadenectomy were divided into 3 groups: N0, no metastases; ITC, metastasis less than 0.2 mm; and micro- or macrometastases (MM), metastasis greater than 0.2 mm. The chi-square test and analysis of variance were used. Results: A total of 552 patients underwent sentinel lymphadenectomy; 197 (36%) had tumor-positive sentinel lymph nodes. Of these, 35 (18%) were classified as ITC and 162 (82%) as MM. When primary tumor characteristics were compared, the ITC group had significantly more lymphovascular invasion and higher proliferative rate than the N0 group (P < .05) and significantly less lymphovascular invasion, lower proliferative rate, and smaller tumor size (P < .05) than the MM group. There were no significant differences in the age, hormone receptor status, histologic type, or tumor grade among the patient groups. Conclusions: Proliferation and lymphovascular invasion of the primary tumor are significantly different between the ITC, N0, and MM groups suggesting that ITC tumors may have different biology than the N0 or MM tumors.

UR - http://www.scopus.com/inward/record.url?scp=51449115296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51449115296&partnerID=8YFLogxK

U2 - 10.1016/j.surg.2008.06.006

DO - 10.1016/j.surg.2008.06.006

M3 - Article

C2 - 18847634

AN - SCOPUS:51449115296

VL - 144

SP - 518

EP - 524

JO - Surgery (United States)

JF - Surgery (United States)

SN - 0039-6060

IS - 4

ER -